Vincent Serra

Suresnes, 92150, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice.

A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice.

Journal: Science translational medicine
Published: December 03, 2025

Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.

Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.

Journal: In vitro models
Published: September 18, 2025

Development of a Conjugate Vaccine Targeting Human IgE for Long-Term Prevention of Anaphylaxis.

Development of a Conjugate Vaccine Targeting Human IgE for Long-Term Prevention of Anaphylaxis.

Journal: Allergy
Published: August 05, 2025

An Anti-IL-13 Vaccine Reduces Atopic Dermatitis in Humanized Mice and Induces Neutralizing Antibodies in Nonhuman Primates.

An Anti-IL-13 Vaccine Reduces Atopic Dermatitis in Humanized Mice and Induces Neutralizing Antibodies in Nonhuman Primates.

Journal: Allergy
Published: June 17, 2025

Assessing IgE and basophil activity in blood samples from nonhuman primates.

Assessing IgE and basophil activity in blood samples from nonhuman primates.

Journal: Allergy
Published: February 15, 2024

A vaccine targeting human IL-4 and IL-13 protects against asthma in humanized mice.

A vaccine targeting human IL-4 and IL-13 protects against asthma in humanized mice.

Journal: Allergy
Published: October 13, 2022

A vaccine targeting the cytokines IL-4 and IL-13 protects against allergic asthma in mice

A vaccine targeting the cytokines IL-4 and IL-13 protects against allergic asthma in mice

Journal: Medecine sciences : M/S
Published: January 21, 2022

Development and preclinical evaluation of a vaccine targeting IL-4 and IL-13 for the treatment of allergic asthma.

Development and preclinical evaluation of a vaccine targeting IL-4 and IL-13 for the treatment of allergic asthma.

Journal: Allergy
Published: May 03, 2021

Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.

Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.

Journal: Nature communications
Published: June 26, 2020

Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination.

Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination.

Journal: Vaccine
Published: May 05, 2014
Showing 1-10 of 10

Last Updated: 09/26/2026